EDIL3 Antibodies

Santa Cruz Biotechnology features a diverse variety of EDIL3 monoclonal antibodies for research focused on understanding EDIL3 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EDIL3, or EGF-like repeats and discoidin I-like domains 3, is a secreted protein that plays a crucial role in cell adhesion, migration, and tissue remodeling. Research has shown EDIL3's involvement in inflammation and wound healing processes, making it a significant focus in cancer and disease-related studies. EDIL3 expression patterns and regulatory mechanisms continue to be active areas of investigation in developmental biology and pathological conditions. Studying EDIL3 can reveal new therapeutic approaches and treatment strategies. Understanding EDIL3's molecular interactions provides valuable insights into cellular signaling pathways and tissue development. Ongoing research utilizing Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific knowledge about EDIL3's role in health and disease.